Experimental medication using encapsulated cell therapy for treating Glaucoma

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation. BrightFocus is helping fund a recently launched, Phase 2 [or mid-level] clinical trial designed to test the new treatment. The trial will be … Continue reading Experimental medication using encapsulated cell therapy for treating Glaucoma